Granules India Ltd., on Wednesday announced that the US FDA has approved its Abbreviated New Drug Applications (ANDA) for Ibuprofen tablets USP, 400 mg, 600 mg, and 800 mg.
"The development will further strengthen our base business and enable us to increase our product offering to our customers in USA.” said C Krishna Prasad, Chairman & Managing Director of Granules India.